|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 31/496 | (2006.01) | ||
| C07D 213/75 | (2006.01) | ||
| A61P 9/04 | (2006.01) |
| (11) | Number of the document | 2968173 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14719472.4 |
| Date of filing the European patent application | 2014-03-14 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-14 |
| (46) | Date of publication of the claims translation | 2021-03-25 |
| (86) | Number | PCT/US2014/027104 |
| Date | 2014-03-14 |
| (87) | Number | WO 2014/152236 |
| Date | 2014-09-25 |
| (30) | Number | Date | Country code |
| 201361785763 P | 2013-03-14 | US |
| (72) |
BI, Mingda, US
KUEHL, Robert, US
|
| (73) |
Cytokinetics, Inc.,
280 East Grand Avenue, South San Francisco, CA 94080,
US
Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, California 91320-1799, US |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Heterocikliniai junginiai ir jų panaudojimas |
| HETEROCYCLIC COMPOUNDS AND THEIR USES |
| Payment date | Validity (years) | Amount | |
| 2025-01-21 | 12 | 289.00 EUR |
| 2026-03-14 |